Cytosorbents (CTSO) Shares Outstanding (Diluted) (2014 - 2026)
Cytosorbents (CTSO) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 393.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 968.53 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 873.00 Mn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 62.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.74 Mn |
| Dec 31, 2025 | 62.23 Mn |
| Sep 30, 2025 | 62.75 Mn |
| Jun 30, 2025 | 67.17 Mn |
| Mar 31, 2025 | 60.73 Mn |
| Dec 31, 2024 | 54.43 Mn |
| Sep 30, 2024 | 54.45 Mn |
| Jun 30, 2024 | 54.31 Mn |
| Mar 31, 2024 | 54.26 Mn |
| Dec 31, 2023 | 44.66 Mn |
| Sep 30, 2023 | 44.37 Mn |
| Jun 30, 2023 | 44.02 Mn |
| Mar 31, 2023 | 43.68 Mn |
| Dec 31, 2022 | 43.57 Mn |
| Sep 30, 2022 | 43.61 Mn |
| Jun 30, 2022 | 43.56 Mn |
| Mar 31, 2022 | 41.59 Mn |
| Dec 31, 2021 | 43.36 Mn |
| Sep 30, 2021 | 43.40 Mn |
| Jun 30, 2021 | 43.32 Mn |